To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TP53I13TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
340 supporting clones for gene TP53I13 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR612916 Placenta Cot 25-normalized .a 1 to 1530 1 to 1530 exact tiling clone,   1530/1530
(100 %)
0 diff
(100 %id)
AL551604 placenta, Placenta Cot 25-normalized .a 1 to 988 1 to 986       986/986
(100 %)
8 diff
(99.2 %id)
AB110209 brain .a 10 to 1529 1 to 1519       1519/1519
(100 %)
1 diff
(100.0 %id)
BI827143 brain, medulla .a 29 to 795 1 to 772       772/773
(99 %)
12 diff
(98.5 %id)
TI_57174457   .a 29 to 795 30 to 801       772/802
(96 %)
11 diff
(98.7 %id)
DB500622 hypothalamus .a 45 to 511 1 to 467       467/467
(100 %)
3 diff
(99.4 %id)
DB466130 hippocampus .a 54 to 429 1 to 379       379/411
(92 %)
28 diff
(93.2 %id)
BQ434724 melanotic melanoma, skin .a 54 to 792 1 to 744       744/948
(78 %)
37 diff
(96.1 %id)
DN997575 breast cancer, Mammary gland (cancer tissue) .a 62 to 649 1 to 588       588/588
(100 %)
5 diff
(99.2 %id)
BM142337 Islets of Langerhans, Pancreas .a 64 to 613 1 to 550       550/550
(100 %)
0 diff
(100 %id)
AK075341   .a 67 to 1529 21 to 1483       1463/1463
(100 %)
0 diff
(100 %id)
BE293160 adenocarcinoma cell line, colon .a 68 to 765 32 to 726       695/734
(94 %)
14 diff
(98.1 %id)
TI_57177377   .a 68 to 794 68 to 790       723/790
(91 %)
13 diff
(98.4 %id)
DA731533   .a 68 to 620 21 to 572   capped   552/554
(99 %)
11 diff
(98.1 %id)
BI830883 brain, medulla .a 69 to 794 1 to 722       722/722
(100 %)
7 diff
(99.1 %id)
TI_57193750   .a 69 to 773 48 to 761       714/926
(77 %)
24 diff
(97.5 %id)
BI861038 breast, mammary adenocarcinoma, cell line .a 70 to 658 1 to 594       594/594
(100 %)
9 diff
(98.5 %id)
DA899357 skeletal muscle .a 71 to 614 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
CN334414 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 73 to 593 1 to 521       521/521
(100 %)
0 diff
(100 %id)
TI_57175768   .a 75 to 855 63 to 839       777/839
(92 %)
11 diff
(98.7 %id)
BM920532 pooled lung and spleen .a 76 to 834 1 to 771       771/1187
(64 %)
24 diff
(98.0 %id)
DB442098 testis .a 77 to 511 1 to 448       446/448
(99 %)
31 diff
(93.1 %id)
BC001593 Colon, adenocarcinoma .a 78 to 1529 1 to 1452   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1452/1452
(100 %)
0 diff
(100 %id)
NM_138349.2   .a 78 to 1529 1 to 1452   RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1452/1452
(100 %)
0 diff
(100 %id)
BI829037 brain, medulla .a 81 to 660 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
CR621821 Placenta Cot 25-normalized .a 82 to 1500 1 to 1419       1419/1419
(100 %)
0 diff
(100 %id)
AL547418 placenta, Placenta Cot 25-normalized .a 82 to 786 1 to 694   fully sequenced,   694/694
(100 %)
7 diff
(99.0 %id)
CN334412 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 84 to 746 1 to 663       663/663
(100 %)
2 diff
(99.7 %id)
CN334415 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 84 to 794 1 to 711       711/711
(100 %)
3 diff
(99.6 %id)
CN334416 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 86 to 741 24 to 679       656/679
(96 %)
7 diff
(99.0 %id)
BU160220 leiomyosarcoma, uterus .a 87 to 846 1 to 765       765/934
(81 %)
41 diff
(95.7 %id)
CR594148 Neuroblastoma Cot 25-normalized .a 88 to 1184 1 to 1097       1097/1097
(100 %)
0 diff
(100 %id)
AL524913 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 88 to 1107 1 to 1007       1007/1030
(97 %)
27 diff
(97.4 %id)
AW968534   .a 89 to 669 1 to 582       582/584
(99 %)
6 diff
(99.0 %id)
BP417742 small intestine .a 89 to 574 1 to 486     Submitted on the opposite strand 486/486
(100 %)
0 diff
(100 %id)
BM905839 leiomyosarcoma, uterus .a 89 to 768 1 to 682       682/1089
(62 %)
9 diff
(99.2 %id)
BM546785 ovary (pool of 3) .a 89 to 988 17 to 924       908/1070
(84 %)
24 diff
(97.8 %id)
CX751910 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 93 to 588 1 to 498     Submitted on the opposite strand 498/683
(72 %)
23 diff
(96.7 %id)
BE292797 adenocarcinoma cell line, colon .a 97 to 759 1 to 660       660/731
(90 %)
23 diff
(96.9 %id)
BU197327 eye, retinoblastoma .a 97 to 938 1 to 854       854/858
(99 %)
19 diff
(97.8 %id)
BM560920 eye, retinoblastoma .a 99 to 742 106 to 750       645/1328
(48 %)
19 diff
(98.6 %id)
BM128510 Islets of Langerhans, Pancreas .a 104 to 596 1 to 493       493/493
(100 %)
0 diff
(100 %id)
CX865824 embryonic stem .a 115 to 805 1 to 690     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 690/690
(100 %)
1 diff
(99.9 %id)
BU192059 large cell carcinoma, lung .a 116 to 954 1 to 845       845/869
(97 %)
14 diff
(98.4 %id)
BF316705 brain, neuroblastoma .a 118 to 661 1 to 544       544/545
(99 %)
8 diff
(98.6 %id)
CX163396 human embryonic stem cells differentiated toan early endodermal cell type .a 120 to 894 1 to 775       775/775
(100 %)
0 diff
(100 %id)
H28813 whole brain .a 121 to 412 1 to 289       289/289
(100 %)
7 diff
(97.6 %id)
BM141942 Islets of Langerhans, Pancreas .a 132 to 614 1 to 483       483/483
(100 %)
0 diff
(100 %id)
AA485199 germinal center B cell .a 137 to 443 1 to 304       304/304
(100 %)
6 diff
(98.1 %id)
R14382.
matches multiple genes
whole brain .a 159 to 486 1 to 327     also hits gene PIK3C2_ 329/327
(100 %)
7 diff
(97.9 %id)
TI_57176645   .a 162 to 949 67 to 854       788/854
(92 %)
8 diff
(99.1 %id)
BI829960 brain, medulla .a 163 to 660 1 to 498       498/498
(100 %)
0 diff
(100 %id)
BG330134 large cell carcinoma, lung .a 339 to 1161 1 to 813       813/829
(98 %)
30 diff
(96.4 %id)
BG422821 Kidney, renal cell adenocarcinoma .a 401 to 1190 1 to 769       720/942
(76 %)
33 diff
(96.5 %id)
BX403840 neuroblastoma .a 427 to 1102 440 to 1105       666/1131
(58 %)
32 diff
(97.2 %id)
BU858038 adenocarcinoma, cell line, breast .a 454 to 1110 1 to 662       662/898
(73 %)
22 diff
(97.6 %id)
BE878140 large cell carcinoma, undifferentiated, lung .a 457 to 638 1 to 182       182/182
(100 %)
0 diff
(100 %id)
AL551564 placenta, Placenta Cot 25-normalized .a 461 to 1474 1005 to 1       1005/1007
(99 %)
22 diff
(97.9 %id)
AJ713923 bone marrow .a 468 to 647 1 to 182       182/182
(100 %)
3 diff
(98.4 %id)
BE732256 choriocarcinoma, placenta .a 504 to 1266 1 to 746       746/747
(99 %)
20 diff
(97.4 %id)
TI_1948218381   .a 504 to 900 142 to 537   fully sequenced,   396/537
(73 %)
7 diff
(98.7 %id)
BI906994 leukocyte .a 510 to 1169 1 to 656       656/660
(99 %)
9 diff
(98.7 %id)
TI_57233542   .a 510 to 1169 26 to 681       656/685
(95 %)
15 diff
(97.9 %id)
CB048985 Prostate .a 531 to 969 1 to 439   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 439/439
(100 %)
4 diff
(99.1 %id)
BM718662 eye, fetal eye .a 552 to 1215 1 to 663   fully sequenced,   663/663
(100 %)
1 diff
(99.9 %id)
BF933065 nervous_tumor .a 569 to 772 1 to 204       204/241
(84 %)
1 diff
(99.6 %id)
BF933069 nervous_tumor .a 569 to 772 1 to 204       204/241
(84 %)
1 diff
(99.6 %id)
BM843364 stomach .a 574 to 1193 1 to 620       620/620
(100 %)
2 diff
(99.7 %id)
BM856597 stomach .a 574 to 796 1 to 223       223/223
(100 %)
1 diff
(99.6 %id)
BQ083704 stomach .a 574 to 1151 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BM819034 stomach .a 574 to 868 1 to 296       296/296
(100 %)
9 diff
(97.0 %id)
BM823583 stomach .a 574 to 1157 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BM823626 stomach .a 574 to 1104 1 to 531       531/531
(100 %)
0 diff
(100 %id)
BM823646 stomach .a 574 to 1004 1 to 431       431/431
(100 %)
1 diff
(99.8 %id)
BM823167 stomach .a 574 to 1075 1 to 502       502/502
(100 %)
3 diff
(99.5 %id)
BM823196 stomach .a 574 to 1040 1 to 467       467/467
(100 %)
2 diff
(99.6 %id)
BM823239 stomach .a 574 to 1040 1 to 466       466/466
(100 %)
4 diff
(99.2 %id)
BM823123 stomach .a 574 to 1038 1 to 465       465/465
(100 %)
1 diff
(99.8 %id)
BM823158 stomach .a 574 to 1019 1 to 446       446/446
(100 %)
1 diff
(99.8 %id)
BM823347 stomach .a 574 to 918 1 to 345       345/345
(100 %)
6 diff
(98.3 %id)
BM823348 stomach .a 574 to 1038 1 to 465       465/465
(100 %)
15 diff
(96.8 %id)
BM823349 stomach .a 574 to 1037 1 to 465       465/465
(100 %)
12 diff
(97.5 %id)
BM823495 stomach .a 574 to 918 1 to 346       346/346
(100 %)
10 diff
(97.2 %id)
BM823505 stomach .a 574 to 1038 1 to 465       465/465
(100 %)
7 diff
(98.5 %id)
BM823524 stomach .a 574 to 1184 1 to 611       611/611
(100 %)
9 diff
(98.6 %id)
BM823538 stomach .a 574 to 968 1 to 396       396/396
(100 %)
11 diff
(97.3 %id)
BM825522 stomach .a 574 to 1013 1 to 440       440/440
(100 %)
0 diff
(100 %id)
BM825577 stomach .a 574 to 1082 1 to 510       510/510
(100 %)
4 diff
(99.3 %id)
BM825669 stomach .a 574 to 994 1 to 421       421/421
(100 %)
0 diff
(100 %id)
BM825711 stomach .a 574 to 877 1 to 303       303/303
(100 %)
2 diff
(99.4 %id)
BM826730 stomach .a 574 to 939 1 to 366       366/366
(100 %)
0 diff
(100 %id)
BM826738 stomach .a 574 to 1004 1 to 430       430/430
(100 %)
1 diff
(99.8 %id)
BM826752 stomach .a 574 to 939 1 to 366       366/366
(100 %)
0 diff
(100 %id)
BM826775 stomach .a 574 to 892 1 to 319       319/319
(100 %)
0 diff
(100 %id)
BM831117 stomach .a 574 to 1109 1 to 537       537/537
(100 %)
3 diff
(99.5 %id)
BM831129 stomach .a 574 to 1161 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
BM831137 stomach .a 574 to 1193 1 to 620       620/620
(100 %)
0 diff
(100 %id)
BM831148 stomach .a 574 to 1028 1 to 455       455/455
(100 %)
1 diff
(99.8 %id)
BM831159 stomach .a 574 to 1167 1 to 594       594/594
(100 %)
1 diff
(99.9 %id)
BM831188 stomach .a 574 to 1187 1 to 614       614/618
(99 %)
4 diff
(99.4 %id)
BM831029 stomach .a 574 to 962 1 to 389       389/389
(100 %)
1 diff
(99.8 %id)
BM831067 stomach .a 574 to 1236 1 to 663       663/663
(100 %)
0 diff
(100 %id)
BM831078 stomach .a 574 to 1193 1 to 620       620/620
(100 %)
0 diff
(100 %id)
BM831108 stomach .a 574 to 1094 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BM830773 stomach .a 574 to 1101 1 to 528       528/528
(100 %)
2 diff
(99.7 %id)
BM830787 stomach .a 574 to 1103 1 to 530       530/530
(100 %)
3 diff
(99.5 %id)
BM830807 stomach .a 574 to 1016 1 to 443       443/443
(100 %)
1 diff
(99.8 %id)
BM830828 stomach .a 574 to 1092 1 to 519       519/519
(100 %)
3 diff
(99.5 %id)
BM830933 stomach .a 574 to 1194 1 to 621       621/622
(99 %)
2 diff
(99.7 %id)
BM830934 stomach .a 574 to 1130 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BM830942 stomach .a 574 to 1192 1 to 619       619/619
(100 %)
0 diff
(100 %id)
BM830973 stomach .a 574 to 993 1 to 420       420/420
(100 %)
0 diff
(100 %id)
BM831005 stomach .a 574 to 1165 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BM831006 stomach .a 574 to 988 1 to 415       415/415
(100 %)
2 diff
(99.6 %id)
BM831009 stomach .a 574 to 1208 1 to 635       635/635
(100 %)
1 diff
(99.9 %id)
BM826887 stomach .a 574 to 763 1 to 190       190/190
(100 %)
1 diff
(99.5 %id)
BM830688 stomach .a 574 to 1092 1 to 519       519/519
(100 %)
2 diff
(99.7 %id)
BM830736 stomach .a 574 to 1122 1 to 549       549/549
(100 %)
2 diff
(99.7 %id)
BM830744 stomach .a 574 to 1107 1 to 534       534/534
(100 %)
2 diff
(99.7 %id)
BM830745 stomach .a 574 to 1040 1 to 467       467/467
(100 %)
1 diff
(99.8 %id)
BM825520 stomach .a 577 to 964 1 to 388       388/388
(100 %)
0 diff
(100 %id)
BM825686 stomach .a 577 to 1003 1 to 427       427/427
(100 %)
3 diff
(99.3 %id)
BM825708 stomach .a 587 to 1147 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
BM555418 amelanotic melanoma, cell line, skin .a 594 to 1110 1 to 518       518/865
(59 %)
12 diff
(98.7 %id)
BM823578 stomach .a 601 to 1083 1 to 484       484/484
(100 %)
4 diff
(99.2 %id)
CA422259 Bone, Enchondroma cell line .a 612 to 909 296 to 593     Submitted on the opposite strand 298/575
(51 %)
0 diff
(100 %id)
BM825649 stomach .a 615 to 884 1 to 270       270/270
(100 %)
2 diff
(99.3 %id)
BX283403 amelanotic melanoma, cell line, skin .a 617 to 1112 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BM826714 stomach .a 619 to 909 1 to 291       291/291
(100 %)
0 diff
(100 %id)
BM825597 stomach .a 620 to 939 1 to 320       320/320
(100 %)
0 diff
(100 %id)
BM712703 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 626 to 1079 1 to 455   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 455/455
(100 %)
1 diff
(99.8 %id)
BM550533 amelanotic melanoma, cell line, skin .a 627 to 1524 35 to 941       907/1114
(81 %)
40 diff
(96.5 %id)
BM823197 stomach .a 630 to 892 1 to 263       263/263
(100 %)
5 diff
(98.1 %id)
BM823201 stomach .a 630 to 892 1 to 263       263/263
(100 %)
2 diff
(99.3 %id)
TI_149315328   .a 631 to 1529 974 to 89   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 886/977
(90 %)
22 diff
(97.8 %id)
BM823162 stomach .a 636 to 892 1 to 257       257/257
(100 %)
3 diff
(98.9 %id)
BM823187 stomach .a 637 to 892 1 to 256       256/256
(100 %)
2 diff
(99.3 %id)
AA258474 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 647 to 984 1 to 339       339/339
(100 %)
14 diff
(95.9 %id)
TI_149314931   .a 657 to 1529 953 to 90   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 864/1018
(84 %)
15 diff
(98.6 %id)
TI_1948218042   .a 665 to 1303 760 to 116       645/1383
(46 %)
25 diff
(98.2 %id)
TI_182940257   .a 666 to 1529 938 to 83   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 856/977
(87 %)
13 diff
(98.7 %id)
CN484087 eye .a 687 to 1339 1 to 653       653/653
(100 %)
0 diff
(100 %id)
BM825634 stomach .a 696 to 921 1 to 226       226/226
(100 %)
0 diff
(100 %id)
BC004507 Placenta, choriocarcinoma .a 706 to 1529 1 to 824   available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 824/824
(100 %)
0 diff
(100 %id)
BE733297 choriocarcinoma, placenta .a 725 to 1522 1 to 787       787/906
(86 %)
12 diff
(98.7 %id)
AL540867 placenta .a 726 to 1530 1 to 805       805/805
(100 %)
2 diff
(99.8 %id)
BU146869 dorsal root ganglia .a 730 to 1367 111 to 750       640/1091
(58 %)
32 diff
(97.1 %id)
BM825660 stomach .a 734 to 946 1 to 213       213/213
(100 %)
5 diff
(97.7 %id)
BM825677 stomach .a 735 to 1096 1 to 362       362/362
(100 %)
1 diff
(99.8 %id)
BM826785 stomach .a 735 to 1147 1 to 413       413/413
(100 %)
3 diff
(99.3 %id)
TI_154113001   .a 735 to 1530 898 to 124       775/1027
(75 %)
33 diff
(96.8 %id)
BM823244 stomach .a 740 to 877 1 to 138       138/138
(100 %)
1 diff
(99.3 %id)
BX355501 Neuroblastoma Cot 50-normalized .a 746 to 1530 1 to 781       781/781
(100 %)
14 diff
(98.3 %id)
AL572464 placenta, Placenta Cot 25-normalized .a 756 to 1481 752 to 20   fully sequenced,   733/752
(97 %)
18 diff
(97.7 %id)
AA443163 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 768 to 1233 1 to 460       460/460
(100 %)
13 diff
(97.2 %id)
C18978 placenta .a 770 to 986 7 to 224       218/225
(96 %)
13 diff
(94.3 %id)
BU622955 cell lines, Chondrosarcoma .a 806 to 1529 741 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 723/723
(100 %)
6 diff
(99.2 %id)
TI_149310928   .a 809 to 1529 805 to 97   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 709/860
(82 %)
14 diff
(98.4 %id)
BM707774 eye, RPE and Choroid .a 813 to 1262 1 to 450   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 450/450
(100 %)
0 diff
(100 %id)
CA432657 cell lines, Chondrosarcoma .a 813 to 1529 733 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 715/715
(100 %)
9 diff
(98.8 %id)
CN480814 Aveolar Macrophage, lung .a 813 to 1529 734 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 718/718
(100 %)
1 diff
(99.9 %id)
BX369300 Placenta Cot 25-normalized .a 835 to 1530 1 to 693       693/693
(100 %)
4 diff
(99.5 %id)
BU633749 cell lines, Chondrosarcoma .a 836 to 1527 710 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 692/692
(100 %)
0 diff
(100 %id)
BU622919 cell lines, Chondrosarcoma .a 843 to 1529 705 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 687/687
(100 %)
0 diff
(100 %id)
BU633082 cell lines, Chondrosarcoma .a 843 to 1529 706 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 688/688
(100 %)
1 diff
(99.9 %id)
CB529142 Aveolar Macrophage, lung .a 843 to 1529 703 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 687/687
(100 %)
0 diff
(100 %id)
BQ045229 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 844 to 1529 702 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 686/686
(100 %)
0 diff
(100 %id)
TI_1948218382   .a 870 to 1303 554 to 113   fully sequenced,   442/554
(79 %)
3 diff
(99.5 %id)
BG339511 leiomyosarcoma cell line, uterus .a 886 to 1531 1 to 647       647/1065
(60 %)
11 diff
(99.0 %id)
BU628375 Bone, Enchondroma cell line .a 886 to 1529 662 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 644/644
(100 %)
1 diff
(99.9 %id)
BQ447181 Knee, Osteoarthritic Cartilage .a 893 to 1529 653 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 637/637
(100 %)
2 diff
(99.7 %id)
BQ072686 leukocyte .a 896 to 1528 20 to 652       633/1246
(50 %)
8 diff
(99.4 %id)
CB306403 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 897 to 1529 649 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 633/633
(100 %)
0 diff
(100 %id)
CA414185 Knee, Osteoarthritic Cartilage .a 938 to 1529 609 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 593/594
(99 %)
1 diff
(99.9 %id)
CB048984 Prostate .a 939 to 1529 618 to 28   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 591/591
(100 %)
0 diff
(100 %id)
CA425326 Bone, Subchondral Bone .a 950 to 1529 598 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 580/580
(100 %)
1 diff
(99.9 %id)
BP423824 small intestine .a 954 to 1453 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BU633563 cell lines, Chondrosarcoma .a 977 to 1530 571 to 18       554/571
(97 %)
3 diff
(99.5 %id)
CX865755 embryonic stem .a 979 to 1527 574 to 26   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 549/549
(100 %)
2 diff
(99.7 %id)
BE883407 leiomyosarcoma, uterus .a 980 to 1520 1 to 544       544/586
(92 %)
8 diff
(98.7 %id)
BU689094 lung .a 982 to 1529 564 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 548/548
(100 %)
0 diff
(100 %id)
BM141684 Islets of Langerhans, Pancreas .a 983 to 1530 550 to 3       548/550
(99 %)
0 diff
(100 %id)
AW138137   .a 984 to 1529 562 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 546/549
(99 %)
1 diff
(99.9 %id)
CA448612 Chondrosarcoma, Left Pelvis .a 993 to 1530 556 to 18       539/556
(96 %)
5 diff
(99.2 %id)
BM142510 Islets of Langerhans, Pancreas .a 1005 to 1529 535 to 11       525/535
(98 %)
0 diff
(100 %id)
CA430223 cell lines, Chondrosarcoma .a 1011 to 1529 539 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 521/521
(100 %)
6 diff
(98.9 %id)
BF591349 colon, colon tumor, RER+ .a 1017 to 1529 513 to 1       513/513
(100 %)
0 diff
(100 %id)
AI924346 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1024 to 1530 508 to 2       507/508
(99 %)
0 diff
(100 %id)
AI492149 B-cell, chronic lymphotic leukemia .a 1029 to 1529 513 to 13   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 501/501
(100 %)
0 diff
(100 %id)
AI739513 colon, colon tumor, RER+ .a 1037 to 1530 497 to 4       494/497
(99 %)
0 diff
(100 %id)
BF448334 carcinoid, lung .a 1039 to 1495 1 to 457     Submitted on the opposite strand 457/457
(100 %)
3 diff
(99.4 %id)
AW450167   .a 1041 to 1459 1 to 419     Submitted on the opposite strand 419/419
(100 %)
2 diff
(99.6 %id)
AI051246 liver and spleen .a 1045 to 1529 495 to 11   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 485/485
(100 %)
3 diff
(99.4 %id)
BM676049 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1049 to 1529 497 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 481/481
(100 %)
0 diff
(100 %id)
BQ002179 Chondrosarcoma, Left Pelvis .a 1050 to 1529 496 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 480/480
(100 %)
0 diff
(100 %id)
AI636530 pooled germ cell tumors .a 1051 to 1530 481 to 2       480/481
(99 %)
0 diff
(100 %id)
AI804622 B-cell, chronic lymphotic leukemia .a 1053 to 1530 478 to 1       478/478
(100 %)
0 diff
(100 %id)
DB571793 hypothalamus .a 1058 to 1529 1 to 472     Submitted on the opposite strand 472/472
(100 %)
2 diff
(99.6 %id)
AW195760 pooled .a 1063 to 1530 471 to 3       469/471
(99 %)
1 diff
(99.8 %id)
DB520391 testis .a 1065 to 1529 1 to 465     Submitted on the opposite strand 465/465
(100 %)
1 diff
(99.8 %id)
AW572547 adenocarcinoma, Pancreas .a 1066 to 1529 464 to 1       464/464
(100 %)
0 diff
(100 %id)
AI458745 carcinoid, lung .a 1068 to 1476 1 to 409     Submitted on the opposite strand 409/409
(100 %)
10 diff
(97.6 %id)
AI870348 anaplastic oligodendroglioma, brain .a 1068 to 1529 462 to 1       462/462
(100 %)
3 diff
(99.4 %id)
AI128117 uterus .a 1072 to 1530 459 to 1       459/459
(100 %)
0 diff
(100 %id)
AI885360 anaplastic oligodendroglioma, brain .a 1079 to 1530 458 to 7       452/458
(98 %)
0 diff
(100 %id)
AI553934 pooled .a 1081 to 1530 451 to 3       449/451
(99 %)
1 diff
(99.8 %id)
AW006777 colon .a 1083 to 1537 455 to 1       455/455
(100 %)
0 diff
(100 %id)
BQ933172 sciatic nerve .a 1086 to 1529 1 to 444   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 444/444
(100 %)
0 diff
(100 %id)
BF433315 carcinoid, lung .a 1093 to 1294 1 to 202     Submitted on the opposite strand 202/202
(100 %)
3 diff
(98.6 %id)
AW084023 esophagus, squamous cell carcinoma .a 1094 to 1529 462 to 26   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 437/437
(100 %)
12 diff
(97.3 %id)
AI360151 anaplastic oligodendroglioma, brain .a 1096 to 1529 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
AI815058 adenocarcinoma, Pancreas .a 1096 to 1530 436 to 2       435/436
(99 %)
0 diff
(100 %id)
AW083929 colon, moderately differentiated adenocarcinoma .a 1096 to 1528 434 to 2       433/434
(99 %)
0 diff
(100 %id)
AI985284 Kidney .a 1103 to 1529 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AA402693 ovarian tumor, ovary .a 1105 to 1529 424 to 1       424/424
(100 %)
6 diff
(98.6 %id)
AW016839   .a 1113 to 1529 434 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 417/417
(100 %)
0 diff
(100 %id)
AW338111 adenocarcinoma, Pancreas .a 1114 to 1530 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
BQ001927 lung, Metastatic Chondrosarcoma .a 1131 to 1529 415 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 399/399
(100 %)
4 diff
(99.0 %id)
AA610282 breast .a 1132 to 1408 278 to 1       278/278
(100 %)
6 diff
(97.9 %id)
BM193784 leukopheresis .a 1136 to 1529 411 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 394/394
(100 %)
0 diff
(100 %id)
AA602631 adrenal adenoma, adrenal gland .a 1140 to 1529 402 to 15   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 388/388
(100 %)
6 diff
(98.5 %id)
AW665451 pooled .a 1140 to 1522 391 to 9       383/391
(97 %)
0 diff
(100 %id)
BQ670910 epidermoid carcinoma, cell line, salivary gland .a 1143 to 1527 1 to 385       385/413
(93 %)
3 diff
(99.3 %id)
AW261903 brain, three pooled meningiomas .a 1149 to 1529 381 to 1       381/381
(100 %)
1 diff
(99.8 %id)
BU742337 eye, fetal eye .a 1154 to 1530 395 to 18   fully sequenced,   378/395
(95 %)
0 diff
(100 %id)
AI572856 lymph node, lymphoma, follicular mixed small and largecell .a 1171 to 1529 359 to 1       359/359
(100 %)
0 diff
(100 %id)
AI250423 lymph node, lymphoma, follicular mixed small and largecell .a 1172 to 1529 358 to 1       358/358
(100 %)
0 diff
(100 %id)
AI675244 Prostate .a 1172 to 1529 357 to 1       357/357
(100 %)
1 diff
(99.8 %id)
AW129129 brain, tumor, 5 pooled (see description) .a 1172 to 1529 377 to 20   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 358/358
(100 %)
2 diff
(99.5 %id)
AI499780 anaplastic oligodendroglioma, brain .a 1174 to 1529 355 to 1       355/355
(100 %)
1 diff
(99.8 %id)
BG056103 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a 1188 to 1530 343 to 1       343/343
(100 %)
0 diff
(100 %id)
AI380326 B-cell, chronic lymphotic leukemia .a 1197 to 1530 335 to 3       333/335
(99 %)
0 diff
(100 %id)
AI871450 anaplastic oligodendroglioma, brain .a 1201 to 1529 329 to 1       329/329
(100 %)
5 diff
(98.5 %id)
AI684970 Kidney .a 1211 to 1529 319 to 1       319/319
(100 %)
2 diff
(99.4 %id)
CN334413 embryonic stem cells, cell lines H1, H7, andH9 .a 1216 to 1529 325 to 12   AAA Submitted on the opposite strand 314/314
(100 %)
4 diff
(98.8 %id)
AI424845 pooled .a 1220 to 1529 326 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 310/310
(100 %)
2 diff
(99.4 %id)
BM128158 Islets of Langerhans, Pancreas .a 1227 to 1529 1 to 303   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 303/303
(100 %)
1 diff
(99.7 %id)
AA807957 normal prostate, Prostate .a 1232 to 1484 253 to 1       253/257
(98 %)
7 diff
(97.3 %id)
BU733286 eye, RPE and Choroid .a 1232 to 1529 316 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 298/298
(100 %)
0 diff
(100 %id)
CK903732 Islets of Langerhans, Pancreas .a 1234 to 1529 1 to 296   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 296/296
(100 %)
0 diff
(100 %id)
AI261485 adenocarcinoma, colon .a 1236 to 1529 312 to 20   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 293/293
(100 %)
12 diff
(96.0 %id)
AA761589 germinal center B cell .a 1240 to 1529 323 to 36   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 288/289
(99 %)
6 diff
(98.0 %id)
BE328245 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 1244 to 1530 291 to 4       288/291
(98 %)
0 diff
(100 %id)
BI964055 Islets of Langerhans, Pancreas .a 1252 to 1529 1 to 278   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 278/278
(100 %)
0 diff
(100 %id)
AI886997 anaplastic oligodendroglioma, brain .a 1268 to 1530 269 to 7       263/269
(97 %)
0 diff
(100 %id)
BF526868 brain, glioblastoma with EGFR amplification .a 1277 to 1529 1 to 253   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 253/253
(100 %)
0 diff
(100 %id)
AA834078 Kidney, kidney tumor .a 1298 to 1488 191 to 1       191/191
(100 %)
0 diff
(100 %id)
BE673594 Prostate .a 1302 to 1530 229 to 1       229/229
(100 %)
0 diff
(100 %id)
AI659253 Prostate .a 1324 to 1529 230 to 25   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 206/206
(100 %)
4 diff
(98.1 %id)
CX163329 human embryonic stem cells differentiated toan early endodermal cell type .a 1330 to 1530 239 to 39       201/239
(84 %)
0 diff
(100 %id)
AW080396 esophagus, squamous cell carcinoma .a 1345 to 1520 176 to 1       176/176
(100 %)
7 diff
(96.1 %id)
EC557352 Prostate .a 1409 to 1527 130 to 11       120/130
(92 %)
0 diff
(100 %id)
AW150456 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1424 to 1529 118 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 107/107
(100 %)
1 diff
(99.1 %id)
BQ574520 Chondrosarcoma Grade II, Left Pelvis .a 1445 to 1531 105 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 87/95
(91 %)
0 diff
(100 %id)
CA441389 Fibrosarcoma .a 1452 to 1529 94 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 78/84
(92 %)
1 diff
(98.9 %id)
CT000579 T-Lymphocytes .b 1 to 498 1 to 506   tiling clone,   506/534
(94 %)
18 diff
(96.7 %id)
CR987110 T-Lymphocytes .b 132 to 897 14 to 779       766/782
(97 %)
8 diff
(99.0 %id)
BF108367 carcinoid, lung .b 217 to 623 1 to 407     Submitted on the opposite strand 407/407
(100 %)
0 diff
(100 %id)
EL735146 mixed .b 431 to 1080 1 to 650       650/650
(100 %)
48 diff
(92.7 %id)
BM802946 duodenal adenocarcinoma, cell line, small intestine .b 459 to 1227 17 to 788   tiling clone,   772/1021
(75 %)
13 diff
(98.8 %id)
BM830987 stomach .b 814 to 1394 1 to 581   tiling clone,   581/581
(100 %)
0 diff
(100 %id)
AW128920 brain, tumor, 5 pooled (see description) .b 1157 to 1575 434 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 419/419
(100 %)
0 diff
(100 %id)
BM264228 Pancreas, Purified pancreatic islet .c 1 to 564 10 to 573   tiling clone,   564/573
(98 %)
6 diff
(99.0 %id)
BG654884 Pancreas, Purified pancreatic islet .c 129 to 470 1 to 342       342/342
(100 %)
6 diff
(98.3 %id)
DA089068 cerebellum .c 407 to 818 2 to 413   tiling clone, capped   412/418
(98 %)
1 diff
(99.8 %id)
AA262110 germinal center B cell .c 794 to 1288 1 to 492     Submitted on the opposite strand 492/501
(98 %)
11 diff
(97.9 %id)
AI283209 adenocarcinoma, colon .c 794 to 1277 1 to 484     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
AI393037 B-cell, chronic lymphotic leukemia .c 794 to 1230 1 to 437     Submitted on the opposite strand 437/437
(100 %)
0 diff
(100 %id)
AW051012 brain, glioblastoma (pooled) .c 794 to 1336 1 to 531     Submitted on the opposite strand 531/589
(90 %)
40 diff
(93.3 %id)
AW572259 cervix .c 794 to 1306 1 to 513     Submitted on the opposite strand 513/513
(100 %)
0 diff
(100 %id)
BE675755 B-cell, chronic lymphotic leukemia .c 794 to 1306 1 to 513     Submitted on the opposite strand 513/513
(100 %)
0 diff
(100 %id)
BF115357 fibrotheoma, ovary .c 794 to 1247 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
TI_157597934   .c 794 to 1278 71 to 562     Submitted on the opposite strand 492/741
(66 %)
13 diff
(98.3 %id)
TI_157603027   .c 794 to 1420 80 to 705     Submitted on the opposite strand 626/1194
(52 %)
14 diff
(98.9 %id)
TI_157603216   .c 794 to 1420 85 to 710     Submitted on the opposite strand 626/1216
(51 %)
9 diff
(99.3 %id)
TI_157603262   .c 794 to 1420 88 to 713   tiling clone, Submitted on the opposite strand 626/1051
(59 %)
8 diff
(99.3 %id)
TI_157604322   .c 794 to 1342 63 to 611     Submitted on the opposite strand 549/612
(89 %)
7 diff
(98.9 %id)
TI_157608973   .c 794 to 1345 60 to 611     Submitted on the opposite strand 552/612
(90 %)
7 diff
(98.9 %id)
TI_158433644   .c 794 to 1404 48 to 664     Submitted on the opposite strand 617/1140
(54 %)
24 diff
(97.9 %id)
BE676442 B-cell, chronic lymphotic leukemia .c 812 to 1306 1 to 495     Submitted on the opposite strand 495/495
(100 %)
0 diff
(100 %id)
AI769663 2 pooled tumors (clear cell type), Kidney .c 821 to 1307 1 to 487     Submitted on the opposite strand 487/487
(100 %)
0 diff
(100 %id)
AI860280 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 838 to 1306 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
AA810636 germinal center B cell .c 876 to 1257 1 to 378     Submitted on the opposite strand 378/378
(100 %)
7 diff
(98.2 %id)
AA768333 germinal center B cell .c 898 to 1261 1 to 363     Submitted on the opposite strand 363/363
(100 %)
2 diff
(99.5 %id)
BG676491 skin, squamous cell carcinoma .c 1309 to 2113 1 to 808 G2R F68L K195N K196E K197E ... tiling clone,   808/808
(100 %)
14 diff
(98.3 %id)
CB594633 Blood, promyelocytic leukemia .d 1 to 708 1 to 717 F42L T188N P189S G190R R191* tiling clone,   717/938
(76 %)
26 diff
(97.3 %id)
CA942884 Pancreas, Purified pancreatic islet .e 1 to 346 1 to 345   tiling clone,   345/345
(100 %)
2 diff
(99.5 %id)
AA327663   .e 390 to 697 1 to 306   tiling clone,   306/306
(100 %)
7 diff
(97.8 %id)
CB999316 Pooled-Skin .e 551 to 1088 1 to 542   tiling clone,   542/805
(67 %)
10 diff
(98.8 %id)
CA942643 Pancreas, Purified pancreatic islet .e 740 to 1273 534 to 1   tiling clone,   534/534
(100 %)
1 diff
(99.9 %id)
AW875037 pnet .e 814 to 1068 1 to 255       255/255
(100 %)
0 diff
(100 %id)
BQ950742 sciatic nerve .f-u 1 to 835 1 to 851   tiling clone,   851/905
(94 %)
30 diff
(96.7 %id)
DA792849 brain .f-u 264 to 754 2 to 492   capped   491/491
(100 %)
0 diff
(100 %id)
DA380368 thalamus .f-u 303 to 832 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
AK093030 esophageal, tumor tissue .f-u 355 to 2822 1 to 2468 exact tiling clone, available from FLJ,   2468/2468
(100 %)
1 diff
(100.0 %id)
AX747867   .f-u 355 to 2822 1 to 2468 exact     2468/2468
(100 %)
1 diff
(100.0 %id)
DB011635 esophageal, tumor tissue .f-u 356 to 910 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA363316 subthalamic nucleus .f-u 365 to 912 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA252788 caudate nucleus .f-u 624 to 1123 2 to 501   capped   500/500
(100 %)
1 diff
(99.8 %id)
DA817380   .f-u 681 to 1243 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BE165836 head_neck .f-u 754 to 1066 318 to 4     Submitted on the opposite strand 315/318
(99 %)
9 diff
(97.2 %id)
BE165870 head_neck .f-u 754 to 1066 318 to 4     Submitted on the opposite strand 315/318
(99 %)
9 diff
(97.2 %id)
DN994698 brain, whole brain .f-u 1577 to 2183 1 to 607       607/607
(100 %)
9 diff
(98.6 %id)
AL137404 testis .f-u 1987 to 2820 1 to 825   available from DKFZ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 825/825
(100 %)
14 diff
(98.4 %id)
DB335333 esophageal, tumor tissue .f-u 2290 to 2822 533 to 1       533/533
(100 %)
0 diff
(100 %id)
TI_153989480   .f-u 2317 to 2823 604 to 98       507/604
(83 %)
0 diff
(100 %id)
AI761038 B-cell, chronic lymphotic leukemia .f-u 2355 to 2823 469 to 1       469/469
(100 %)
4 diff
(99.2 %id)
AI952279 lung, two pooled squamous cell carcinomas .f-u 2355 to 2823 473 to 5   tiling clone,   469/473
(99 %)
0 diff
(100 %id)
AW205517   .f-u 2420 to 2823 420 to 17       404/422
(95 %)
0 diff
(100 %id)
AW009782 colon .f-u 2453 to 2822 370 to 1       370/370
(100 %)
0 diff
(100 %id)
BG771107 adenocarcinoma, Prostate .g 1 to 712 1 to 717   tiling clone,   719/837
(85 %)
12 diff
(98.6 %id)
DR006640 Spleen .g 157 to 858 1 to 702   tiling clone,   702/702
(100 %)
6 diff
(99.2 %id)
BM263927 Pancreas, Purified pancreatic islet .h 1 to 244 244 to 1   tiling clone,   244/244
(100 %)
0 diff
(100 %id)
BM271720 Pancreas, Purified pancreatic islet .h 5 to 318 314 to 1   tiling clone,   314/314
(100 %)
0 diff
(100 %id)
AI923687 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .h 316 to 912 1 to 597   tiling clone, Submitted on the opposite strand 597/597
(100 %)
0 diff
(100 %id)
AA282551 germinal center B cell .h 318 to 630 1 to 313     Submitted on the opposite strand 313/313
(100 %)
8 diff
(97.5 %id)
AI431447 lymph node, lymphoma, follicular mixed small and largecell .h 344 to 710 1 to 367     Submitted on the opposite strand 367/367
(100 %)
0 diff
(100 %id)
AW136235   .h 675 to 1047 17 to 389     Submitted on the opposite strand 373/389
(95 %)
6 diff
(98.5 %id)
AI768551 Kidney .h 691 to 1190 1 to 500     Submitted on the opposite strand 500/500
(100 %)
1 diff
(99.8 %id)
CB052422 leiomyosarcoma, soft tissue .h 718 to 1356 647 to 9   tiling clone, Submitted on the opposite strand 639/647
(98 %)
0 diff
(100 %id)
H23628 brain .h 729 to 957 1 to 226   fully sequenced, Submitted on the opposite strand 226/226
(100 %)
6 diff
(97.4 %id)
CA397869 eye, RPE/choroid .h 793 to 1367 575 to 1   tiling clone, Submitted on the opposite strand 575/575
(100 %)
1 diff
(99.9 %id)
DA284519 corpus callosum .h 923 to 1480 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
H23672 brain .h 927 to 1239 319 to 1   fully sequenced, Submitted on the opposite strand 319/319
(100 %)
6 diff
(98.2 %id)
BQ642166 lymph, lymphoma, cell line .h 943 to 1525 27 to 614       588/888
(66 %)
26 diff
(97.1 %id)
AA282653 germinal center B cell .h 944 to 1292 346 to 1     Submitted on the opposite strand 346/346
(100 %)
7 diff
(98.0 %id)
BQ064136 lymph, lymphoma, cell line .h 944 to 1644 1 to 706   tiling clone,   706/1037
(68 %)
8 diff
(99.3 %id)
BM759312 Ascites, stomach .h 1372 to 1895 1 to 524       524/524
(100 %)
2 diff
(99.7 %id)
BM759324 Ascites, stomach .h 1372 to 1763 1 to 391       391/391
(100 %)
3 diff
(99.3 %id)
BM763737 Ascites, stomach .h 1372 to 1851 1 to 480       480/480
(100 %)
0 diff
(100 %id)
BM763757 Ascites, stomach .h 1372 to 2035 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
BM781681 Ascites, stomach .h 1372 to 1852 1 to 481       481/481
(100 %)
0 diff
(100 %id)
BG830218 epithelioid carcinoma cell line, Pancreas .h 1469 to 2221 1 to 750   tiling clone,   750/750
(100 %)
10 diff
(98.7 %id)
DB454986 testis .i 1 to 496 1 to 496   tiling clone,   496/496
(100 %)
1 diff
(99.8 %id)
BF662949 B-cells, primary B-cells from tonsils (cell line) .j 1 to 741 1 to 734 A89G G90E A91P H92I C93V ... tiling clone,   734/884
(83 %)
13 diff
(98.6 %id)
DA642360 Liver .k 1 to 240 2 to 241 exact tiling clone, capped   240/240
(100 %)
0 diff
(100 %id)
CN291788 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 1 to 446 1 to 446 exact tiling clone,   446/446
(100 %)
0 diff
(100 %id)
CB989137 Human Placenta, placenta .m 1 to 683 23 to 713 L43P Y44L H45P C47L A48C ... tiling clone,   691/822
(84 %)
15 diff
(98.2 %id)
DB185862 liver, tumor tissue .n 1 to 584 2 to 585   tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
CB216152 normal endometrium, mid-secretory phase,cycle day 23, uterus .n 114 to 725 1 to 612   tiling clone,   612/612
(100 %)
2 diff
(99.7 %id)
AW136429   .o 1 to 351 368 to 18 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 351/351
(100 %)
2 diff
(99.5 %id)
BM148077 leukopheresis Gene TP53I13, variant not shown         This clone was ignored    
BM982630 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene TP53I13, variant not shown       AAA Suspected internal deletion, this clone was ignored    
ES314259 occipital scalp hair, skin Gene TP53I13, variant not shown         Suspected internal deletion, this clone was ignored    
AW875035 pnet Gene TP53I13, variant not shown         Suspected internal deletion, this clone was ignored    
BI837017 pooled pancreas and spleen Gene TP53I13, variant not shown         This clone was ignored    
TI_57164048   Gene TP53I13, variant not shown         This clone was ignored    
AW271274 Kidney Gene TP53I13, variant not shown         Suspected internal deletion, this clone was ignored    
BF001462 colon, colon tumor, RER+ Gene TP53I13, variant not shown         Suspected internal deletion, this clone was ignored    
BF001508 colon, colon tumor, RER+ Gene TP53I13, variant not shown         Suspected internal deletion, this clone was ignored    
BE269545 Burkitt lymphoma, lymph Gene TP53I13, variant not shown         This clone was ignored    
BI909891 leukocyte Gene TP53I13, variant not shown         This clone was ignored    
TI_57237652   Gene TP53I13, variant not shown         This clone was ignored    
TI_149297597   Gene TP53I13, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j, .k, .l, .m, .n, .o Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C